Julie Harriague

2.6k total citations · 1 hit paper
15 papers, 2.1k citations indexed

About

Julie Harriague is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Julie Harriague has authored 15 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Julie Harriague's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (3 papers). Julie Harriague is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (3 papers). Julie Harriague collaborates with scholars based in France, Belgium and United Kingdom. Julie Harriague's co-authors include Fernando Arenzana‐Seisdedos, Georges Bismuth, Bernard Lagane, Karl Balabanian, Françoise Bachelerie, Ken Y.C. Chow, Barbara Moepps, Simona Infantino, Marcus Thelen and Ali Dalloul and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Julie Harriague

15 papers receiving 2.1k citations

Hit Papers

The Chemokine SDF-1/CXCL1... 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Harriague France 13 1.2k 941 524 200 187 15 2.1k
Ryuichi Amakawa Japan 23 2.2k 1.9× 648 0.7× 638 1.2× 265 1.3× 145 0.8× 59 3.0k
Chamorro Somoza United Kingdom 17 1.6k 1.4× 416 0.4× 574 1.1× 238 1.2× 179 1.0× 22 2.3k
Dagmar Breitfeld Germany 5 2.7k 2.3× 1.0k 1.1× 405 0.8× 191 1.0× 223 1.2× 7 3.3k
Kohei Kometani Japan 28 2.2k 1.9× 586 0.6× 987 1.9× 275 1.4× 89 0.5× 41 3.4k
Francesco Marangoni United States 22 1.5k 1.3× 889 0.9× 601 1.1× 127 0.6× 266 1.4× 40 2.5k
Jacob Glanville United States 23 2.4k 2.0× 696 0.7× 1.3k 2.5× 355 1.8× 224 1.2× 35 3.7k
Annaiah Cariappa United States 24 2.4k 2.1× 344 0.4× 958 1.8× 205 1.0× 168 0.9× 34 3.3k
Tatyana Chtanova Australia 21 2.0k 1.7× 518 0.6× 471 0.9× 252 1.3× 133 0.7× 36 2.8k
Thomas Eisenreich United States 11 1.8k 1.5× 434 0.5× 902 1.7× 269 1.3× 71 0.4× 15 2.7k
Shinya Suzu Japan 30 1.3k 1.1× 646 0.7× 909 1.7× 292 1.5× 113 0.6× 96 2.7k

Countries citing papers authored by Julie Harriague

Since Specialization
Citations

This map shows the geographic impact of Julie Harriague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Harriague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Harriague more than expected).

Fields of papers citing papers by Julie Harriague

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Harriague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Harriague. The network helps show where Julie Harriague may publish in the future.

Co-authorship network of co-authors of Julie Harriague

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Harriague. A scholar is included among the top collaborators of Julie Harriague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Harriague. Julie Harriague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Moreira, Marta, Otávio Cintra, Julie Harriague, William P. Hausdorff, & Bernard Hoet. (2016). Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program. Vaccine. 34(25). 2766–2778. 26 indexed citations
2.
Taylor, Stuart A., Paola Marchisio, Anne Vergison, et al.. (2012). Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review. Clinical Infectious Diseases. 54(12). 1765–1773. 110 indexed citations
3.
Balabanian, Karl, Angélique Levoye, Bernard Lagane, et al.. (2008). Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. Journal of Clinical Investigation. 118(3). 1074–84. 102 indexed citations
4.
Lagane, Bernard, Ken Y.C. Chow, Karl Balabanian, et al.. (2008). CXCR4 dimerization and β-arrestin–mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood. 112(1). 34–44. 130 indexed citations
5.
Fabre, Stéphanie, Valérie Lang, Julie Harriague, et al.. (2005). Stable Activation of Phosphatidylinositol 3-Kinase in the T Cell Immunological Synapse Stimulates Akt Signaling to FoxO1 Nuclear Exclusion and Cell Growth Control. The Journal of Immunology. 174(7). 4161–4171. 92 indexed citations
6.
Depoil, David, Rossana Zaru, Martine Guiraud, et al.. (2005). Immunological Synapses Are Versatile Structures Enabling Selective T Cell Polarization. Immunity. 22(2). 185–194. 127 indexed citations
7.
Lozach, Pierre‐Yves, Laura Burleigh, Isabelle Staropoli, et al.. (2005). Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN)-mediated Enhancement of Dengue Virus Infection Is Independent of DC-SIGN Internalization Signals. Journal of Biological Chemistry. 280(25). 23698–23708. 196 indexed citations
8.
Balabanian, Karl, Bernard Lagane, Simona Infantino, et al.. (2005). The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes. Journal of Biological Chemistry. 280(42). 35760–35766. 841 indexed citations breakdown →
9.
Balabanian, Karl, Julie Harriague, Bernard Lagane, et al.. (2004). CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes. The Journal of Immunology. 173(12). 7150–7160. 74 indexed citations
10.
Harriague, Julie, et al.. (2004). Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation. Journal of Cell Science. 117(22). 5269–5282. 79 indexed citations
11.
Gary‐Gouy, Hélène, Julie Harriague, Ali Dalloul, Emmanuel Donnadieu, & Georges Bismuth. (2002). CD5-Negative Regulation of B Cell Receptor Signaling Pathways Originates from Tyrosine Residue Y429 Outside an Immunoreceptor Tyrosine-Based Inhibitory Motif. The Journal of Immunology. 168(1). 232–239. 45 indexed citations
12.
Feuillet, Vincent, Monique Sémichon, Audrey Restouin, et al.. (2002). The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions. Oncogene. 21(47). 7205–7213. 7 indexed citations
13.
Harriague, Julie & Georges Bismuth. (2002). Imaging antigen-induced PI3K activation in T cells. Nature Immunology. 3(11). 1090–1096. 133 indexed citations
14.
Gary‐Gouy, Hélène, Julie Harriague, Georges Bismuth, et al.. (2002). Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood. 100(13). 4537–4543. 167 indexed citations
15.
Harriague, Julie, Patrice Debré, Georges Bismuth, & Pascale Hubert. (2000). Priming of CD2-induced p62Dok tyrosine phosphorylation by CD3 in Jurkat T cells. European Journal of Immunology. 30(11). 3319–3328. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026